Correlation Between Bio Gene and Capitol Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and Capitol Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Capitol Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and Capitol Health, you can compare the effects of market volatilities on Bio Gene and Capitol Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Capitol Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Capitol Health.

Diversification Opportunities for Bio Gene and Capitol Health

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Bio and Capitol is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Capitol Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capitol Health and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Capitol Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capitol Health has no effect on the direction of Bio Gene i.e., Bio Gene and Capitol Health go up and down completely randomly.

Pair Corralation between Bio Gene and Capitol Health

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Capitol Health. In addition to that, Bio Gene is 1.88 times more volatile than Capitol Health. It trades about -0.01 of its total potential returns per unit of risk. Capitol Health is currently generating about 0.03 per unit of volatility. If you would invest  30.00  in Capitol Health on September 20, 2024 and sell it today you would earn a total of  9.00  from holding Capitol Health or generate 30.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bio Gene Technology  vs.  Capitol Health

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Capitol Health 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Capitol Health are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain forward-looking indicators, Capitol Health unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bio Gene and Capitol Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and Capitol Health

The main advantage of trading using opposite Bio Gene and Capitol Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Capitol Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capitol Health will offset losses from the drop in Capitol Health's long position.
The idea behind Bio Gene Technology and Capitol Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories